Objective of BINASP is to build-up a system of bio-nanotechnology research infrastructures and facilities in AREA Science Park within the newly formed "TDMB-Technology District of Molecular Biomedicine" set up in the Region FVG at the end of 2004 with th e endorsement of the Italian Ministry of Education, University and Research. The core and main driver of the TDMB is the "CBM-Centre for Biomolecular Medicine", a syndicated company leaded by the Consorzio AREA which presently involves 15 shareholders, in cluding research institutions, hi-tech manufacturing companies and financial institutes. BINASP's s goal will be achieved starting from the assets of the CBM and from the renowned European milieu of ASP, one of the largest European science & technolo gy parks. Cornerstones of BINASP: - to promote research in nanotechnology applied to biology and medicine, and develop advanced instrumentation; - to develop collaborations with EU Nanotech R&D Centers, through the organization of scientific meetings, joint research projects, exchange programs; - to develop hi-education programmes by the promotion of PhD, start-up grants and fellowships; - to manage advanced instrumentation and laboratories for common R&D use, provide consultancy to fund raising an d management for partners and others institutions; - to set-up products, to provide services and instruments useful to diagnostic and therapeutic purposes; - to exploit the market value of the relevant research results. Initial funding and locations of th e project will be provided by the BINASP Partners as well as other public-private institutions; the project sustainability will be subsequently affirmed by the same institutions as well as by grants and market revenues of the intellectual property. BINASP fulfills the goals of the FP6, since it provides the basis of a European cross-cutting hi-tech platform development starting from the existing bulk of sectorial excellence competence centres.
Call for proposal
See other projects for this call